Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX004 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
139.0 |
Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 10 |
Q01DX004 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
147.0 |
Antitumor endpoint evaluated on day 76; 08/08 animals surviving on day 11 |
Q01DX004 (ip) |
median survival time |
saline |
3.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 02/08 animals surviving on day 10 |
Q01DX004 (ip) |
median survival time |
saline |
3.0 mg/kg/injection |
164.0 |
Antitumor endpoint evaluated on day 76; 07/08 animals surviving on day 11 |
Q03DX002 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
149.0 |
Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 10 |
Q03DX002 (ip) |
median survival time |
saline |
6.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 04/08 animals surviving on day 10 |